Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 31 - Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
Patents for A61P 31 - Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics (179,784)
10/1999
10/14/1999WO1999051212A2 Device for the transdermal delivery of diclofenac
10/14/1999WO1999051202A2 Quinolone containing liposomes and their use as antibacterial agents
10/14/1999WO1999051188A2 A polypeptide comprising the amino acid of an n-terminal choline binding protein a truncate, vaccine derived therefrom and uses thereof
10/14/1999WO1999051187A2 A polypeptide comprising the amino acid of an n-terminal choline binding protein a truncate, vaccine derived therefrom and uses thereof
10/14/1999WO1999051097A1 Compositions containing a combination of a creatine compound and a second agent
10/14/1999WO1999042076A3 Compounds and methods for immunotherapy and diagnosis of tuberculosis
10/14/1999WO1999037678A3 Antimicrobial peptides
10/14/1999WO1999036544A3 Neisseria meningitidis antigens
10/14/1999WO1999035157B1 Novel erythromycin derivatives
10/14/1999CA2327095A1 Compositions containing a combination of a creatine compound and a second agent
10/14/1999CA2326884A1 Thiazolo¬4,5-d|pyrimidines and pyridines as corticotropin releasing factor (crf) antagonists
10/14/1999CA2326650A1 Azo and diaza dericatives and uses thereof in phototherapy
10/14/1999CA2326606A1 Aminoalkyl substituted 9h-pyridino¬2,3-b|indole and 9h-pyrimidino¬4,5-b|indole derivatives:crf1 and npy1 receptors
10/14/1999CA2326598A1 Fusion proteins of mycobacterium tuberculosis antigens and their uses
10/14/1999CA2326497A1 Liposome composition and method for administering a quinolone
10/14/1999CA2326388A1 A polypeptide comprising the amino acid of an n-terminal choline binding protein a truncate, vaccine derived therefrom and uses thereof
10/14/1999CA2326383A1 Aminoalkyl substituted pyrrolo¬2,3-b|pyridine and pyrrolo¬2,3-d|pyrimidine derivatives: modulators of crf1 receptors
10/14/1999CA2326319A1 Aminoalkyl substituted 5,6,7,8-tetrahydro-9h pyrimidino¬2,3-b|indole and 5,6,7,8-tetrahydro-9h-pyrimidino¬4,5-b|indole derivatives: crf1 specific ligands
10/14/1999CA2325562A1 Lyst protein complexes and lyst interacting proteins
10/14/1999CA2325400A1 Device for the transdermal delivery of diclofenac
10/14/1999CA2325340A1 Derivatives of pneumococcal choline binding proteins for vaccines
10/14/1999CA2324983A1 Hiv-specific cytotoxic t-cell responses
10/14/1999CA2323965A1 Process for the production of purine derivatives
10/13/1999EP0949333A1 Mutant measles virus antigens and genes encoding the same
10/13/1999EP0949262A1 Cephem compounds
10/13/1999EP0949249A1 Process for producing imidazole derivatives
10/13/1999EP0949245A1 Process for alkylating hindered sulfonamides
10/13/1999EP0948967A2 Treatment of viral disease in swine
10/13/1999EP0948646A1 Methods for identifying genes essential to the growth of an organism
10/13/1999EP0948637A1 Live recombinant avian vaccine, using the infectious laryngotracheitis avian virus as vector
10/13/1999EP0948632A1 Methods for the characterization and selection of rna target motifs that bind compounds of pharmaceutical use
10/13/1999EP0948625A2 USPA1 AND USPA2 ANTIGENS OF $i(MORAXELLA CATARRHALIS)
10/13/1999EP0948624A2 Mutants of streptococcal toxin a and methods of use
10/13/1999EP0948620A2 Secreted proteins and polynucleotides encoding them
10/13/1999EP0948616A2 Riboflavin mutants as vaccines against actinobacillus pleuropneumoniae
10/13/1999EP0948545A1 Antibodies specifically recognising a nitrosylated protein, method of preparation, therapeutic and diagnostic use
10/13/1999EP0948544A1 Monovalent antibody fragments
10/13/1999EP0948535A1 Novel lanthionine antibiotic compositions and methods
10/13/1999EP0948534A1 Meningococcus vaccine comprising the valence of bz83 strain
10/13/1999EP0948528A2 $i(STREPTOCOCCUS UBERIS) LACTOFERRIN-BINDING PROTEIN
10/13/1999EP0948527A1 Cyclosporin derivatives, their preparation and pharmaceutical compositions containing them
10/13/1999EP0948523A1 Peptidomimetic inhibitors of the human cytomegalovirus protease
10/13/1999EP0948511A2 Chemical synthesis of nucleosides analogs and their incorporation into polynucleotides
10/13/1999EP0948510A1 Immunostimulatory nucleic acid molecules
10/13/1999EP0948508A1 Novel coding sequences from herpes simplex virus type-2
10/13/1999EP0948500A1 Cyclic organoselenium compounds, their preparation and their uses
10/13/1999EP0948495A1 Aryl and heteroaryl substituted fused pyrrole antiinflammatory agents
10/13/1999EP0948491A1 Aminothiazole derivatives useful in the preparation of beta-lactam antibiotics
10/13/1999EP0948478A1 ARYL OR HETEROARYL SUBSTITUTED 3,4-DIHYDROANTHRACENE AND ARYL OR HETEROARYL SUBSTITUTED BENZO 1,2-g]-CHROM-3-ENE, BENZO 1,2-g]-THIOCHROM-3-ENE AND BENZO 1,2-g]-1,2-DIHYDROQUINOLINE DERIVATIVES HAVING RETINOID ANTAGONIST OR RETINOID INVERSE AGONIST TYPE BIOLOGICAL ACTIVITY
10/13/1999EP0948359A1 Compositions containing lipophilic oligosaccharide antibiotic and albumin
10/13/1999EP0948352A1 Chlamydia vaccines
10/13/1999EP0948345A1 Pharmaceutical composition containing an inhibitor of immunoglobulin-receptor interaction
10/13/1999EP0948332A1 Antiherpetic pharmaceutical compositions containing acyclovir for topical applicators
10/13/1999EP0948319A2 Encapsulated cells producing antibodies
10/13/1999EP0948256A1 Induction of viral mutation by incorporation of miscoding ribonucleoside analogs into viral rna
10/13/1999EP0936912A4 Inhibitors of cysteine protease
10/13/1999EP0850300B1 Method of modulating gene expression with reduced immunostimulatory response
10/13/1999EP0695185B1 Use of adenosine for the manufacture of a medicament for the treatment of pulmonary inflammatory reactions
10/13/1999EP0672192B1 Method for inhibition of viral morphogenesis
10/13/1999EP0574457B1 Antiviral nucleoside combination
10/13/1999EP0540609B1 Cephalosporins and homologues, preparations and pharmaceutical compositions
10/13/1999CN1231674A Use of proteins as anti-retroviral agents
10/13/1999CN1231665A Azabicyclic carbamoyloxy mutilin derivatives for antibacterial use
10/13/1999CN1231614A Method of producing active immunity with vaccine conjugate
10/13/1999CN1231612A Inhibition of 2,3-dihydrogen-indone to 26S and 20S prolease
10/13/1999CN1231611A Puring inhibitors of cylin dependent kinase 2 and I'kappa'beta-'alpha'
10/13/1999CN1231609A Antimycotic gel with active substance release
10/13/1999CN1231608A Use of PKC inhibitors for the manufacture of a medicament for the treatment of HTLV-1 infections
10/13/1999CN1231607A Use of inhibitors of PKG for the manufacture of a medicament for the treatment of central nervous system diseases associated with HIV infection
10/13/1999CN1231606A Composition comprising mupirocin and chlorhexidine
10/13/1999CN1045604C Process for the production of clavulanic acid salts
10/13/1999CN1045601C Novel quinuclidine derivatives and medicinal composition thereof
10/13/1999CN1045596C Heterocyclic benzenesulfonylimine derivatives as inhibitors of IL-1 action
10/12/1999US5965726 Method of eliminating inhibitory/ instability regions of mRNA
10/12/1999US5965725 Polypeptides, and preparation and DNA encoding thereof
10/12/1999US5965720 With sequence complementary to messenger rna from a gene selected from the group consisting of c-myc, c-myb, c-fos, c-kit, ras and bcr/abl; antisense/anticarcinogenic agents
10/12/1999US5965610 Mixture containing chlorhexidine gluconate and zinc gluconate
10/12/1999US5965609 An antitumor agent, antimalaria agent, bactericide treating gram-negative bacteria and active drug treating stroke, traumatic brain injury, chronic neurodegenerative disease, alzheimer's disease or amyotropic lateral schlerosis
10/12/1999US5965606 Retinoid receptors, 2-fluoro-4-(2',2',4',4'-tetramethyl-8'-trifluoromethylchroman-6' -yl)carbamoyl benzoic acid for treating monocytic leukemia
10/12/1999US5965604 Antibacterial and antitumor activities; produced by culturing streptomyces an recovering compound
10/12/1999US5965601 Novel compounds for inhibiting replication of a retrovirus; treating hiv
10/12/1999US5965588 Sulfonylalkanoylamino hydroxyethylamimo sulfonamides useful as retroviral protease inhibitors
10/12/1999US5965572 Methods for treating antibiotic-resistant infections
10/12/1999US5965564 Enantiomerically pure hydroxylated xanthine compounds
10/12/1999US5965553 Anticholesterol agents, hypotriglyceridemic agents, antiatherosclerosis agents, antifungal agents, alzheimer's agents or anti-acne agents
10/12/1999US5965532 Low molecular weight, synthetic crosslinking boron compounds as an agonists or antagonists and induce association between naturally occurring receptors, t cell surface receptor
10/12/1999US5965527 Cyclosporin a sulfided at the 3 position by r-(ch)n-s-by reacting a lithium-activated derivative with the disulfide; synergistic mixture with a retrovirus viricide; side-effect reduction; aids and arc (aids related complex)
10/12/1999US5965493 Therapeutic Quassinoid preparations with antineoplastic, antiviral, and herbistatic activity
10/12/1999US5965435 Genetically engineered genes containing the herpes virus of turkeys gc gene, thymidine kinase region of marek's disease virus, infectious laryngotracheitis virus's open reading frame and ribonucleotide reductase genes; for vaccines
10/12/1999US5965420 A protein which stimulates cell proliferation; treatment of bone loss due to osteoporosis; treat adult respiratory disease syndrome, parkinson'disease, huntington's disease; antiarthritic/anticarcinogenic agents; antiallergens
10/12/1999US5965416 Arginyl tRNA synthetase from staphyloccus aureus
10/12/1999US5965407 Anthracycline compound 0624
10/12/1999US5965396 Human lymph node derived GTPase
10/12/1999US5965388 Isolated polynucleotides; diagnosis and treatment autoimmune diseases, tissue rejection, allergies, acquired immune deficiency disease; viricides, bactericides and fungicides; anticarcinogenic agents
10/12/1999US5965382 Nucleic acid encoding secreted Mac-2 binding glycoprotein
10/12/1999US5965381 A mutant strain deficient in producing functional effector proteins; used for heterologous protein transfer into antigen presenting cells; treating infections by pathogens; inducing cellular immune response
10/12/1999US5965353 An epitope; for a diagnostic kit
10/12/1999US5965158 Liposomal-polyene preliposomal powder and method for its preparation
10/12/1999US5965156 Amphotericin B liposome preparation
10/12/1999US5965141 Epitopic regions of pneumococcal surface protein a
1 ... 1493 1494 1495 1496 1497 1498 1499 1500 1501 1502 1503 1504 1505 1506 1507 1508 1509 1510 1511 1512 1513 ... 1798